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Abstract: Hydrogel nanoparticles (HNP) are an emerging tool of biomedicine with unique materials
characteristics, scope, and utility. These hydrated, soft colloidal carriers can penetrate through voids
with dimensions narrower than the size of the particle, provide stabilization for fragile biological cargo
and allow diffusion and exchange of solutes with external phase. However, techniques to assemble HNP
are few; solitary examples exist of biocompatible polymers being formulated into HNP; and knowledge on
the biomedical properties of HNP remains rather cursory. In this work, we investigate assembly of HNP
based on a polymer with decades of prominence in the biomedical field, poly(vinyl alcohol), PVA. We
develop a novel method for production of PVA HNP through nanoprecipitation-based assembly of polymer
nanoparticles and subsequent physical hydrogelation of the polymer. Polymer nanoparticles and HNP
were visualized using scanning electron microscopy and fluorescence imaging, and characterized using
dynamic light scattering and zeta potential measurements. Interaction of PVA HNP with mammalian cells
was investigated using flow cytometry, viability screening, and measurements of nitric oxide production
by cultured macrophages. The latter analyses revealed that PVA administered as a polymer solution
or in the form of HNP resulted in no measurable increase in production of the inflammation marker.
Unexpectedly, PVA HNP exerted a pronounced inhibition of NO synthesis by stimulated macrophages,
that is, had an anti-inflammatory activity. This effect was accomplished with a negligible change in the
cell viability and was not observed when PVA was administered as a polymer solution. To the best of
our knowledge, this is the first observation of inhibition of NO synthesis in macrophages by administered
nanoparticles and specifically hydrogel nanoparticles. Taken together, our results present PVA HNP
as promising colloidal hydrogel nanocarriers for biomedical applications, specifically drug delivery and
assembly of intracellular biosensors.
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  ABSTRACT	  
Hydrogel	  nanoparticles	  (HNP)	  are	  an	  emerging	  tool	  of	  biomedicine	  with	  unique	  materials	  characteristics,	  
scope,	  and	  utility.	  These	  hydrated,	  soft	  colloidal	  carriers	  can	  penetrate	  through	  voids	  with	  dimensions	  
narrower	  than	  the	  size	  of	  the	  particle,	  provide	  stabilization	  for	  fragile	  biological	  cargo,	  and	  allow	  diffusion	  
and	  exchange	  of	  solutes	  with	  external	  phase.	  However,	  techniques	  to	  assemble	  HNP	  are	  few;	  solitary	  
examples	  exist	  of	  biocompatible	  polymers	  being	  formulated	  into	  HNP;	  and	  knowledge	  on	  the	  biomedical	  
properties	  of	  HNP	  remains	  rather	  cursory.	  In	  this	  work,	  we	  investigate	  assembly	  of	  HNP	  based	  on	  a	  polymer	  
with	  decades	  of	  prominence	  in	  the	  biomedical	  filed,	  poly(vinyl	  alcohol),	  PVA.	  We	  develop	  a	  novel	  method	  
for	  production	  of	  PVA	  HNP	  through	  nanoprecipitation	  –	  based	  assembly	  of	  polymer	  nanoparticles	  and	  
subsequent	  physical	  hydrogelation	  of	  the	  polymer.	  Polymer	  nanoparticles	  and	  HNP	  were	  visualized	  using	  
scanning	  electron	  microscopy	  and	  fluorescence	  imaging,	  and	  characterized	  using	  dynamic	  light	  scattering	  
and	  zeta	  potential	  measurements.	  Interaction	  of	  PVA	  HNP	  with	  mammalian	  cells	  was	  investigated	  using	  
flow	  cytometry,	  viability	  screening,	  and	  measurements	  of	  nitric	  oxide	  production	  by	  cultured	  macrophages.	  
The	  latter	  analyses	  revealed	  that	  PVA	  administered	  as	  a	  polymer	  solution	  or	  in	  the	  form	  of	  HNP	  resulted	  in	  
no	  measurable	  increase	  in	  production	  of	  the	  inflammation	  marker.	  Unexpectedly,	  PVA	  HNP	  exerted	  a	  
pronounced	  inhibition	  of	  NO	  synthesis	  by	  stimulated	  macrophages,	  i.e.	  had	  an	  anti-­‐inflammatory	  activity.	  
This	  effect	  was	  accomplished	  with	  a	  negligible	  change	  in	  the	  cell	  viability	  and	  was	  not	  observed	  when	  PVA	  
was	  administered	  as	  a	  polymer	  solution.	  To	  the	  best	  of	  our	  knowledge,	  this	  is	  the	  first	  observation	  of	  
inhibition	  of	  NO	  synthesis	  in	  macrophages	  by	  administered	  nanoparticles	  and	  specifically	  hydrogel	  
nanoparticles.	  Taken	  together,	  our	  results	  present	  PVA	  HNP	  as	  promising	  colloidal	  hydrogel	  nanocarriers	  
for	  biomedical	  applications,	  specifically	  drug	  delivery	  and	  assembly	  of	  intracellular	  biosensors.	  
	  
	   	  
INTRODUCTION	  
Nanotechnology	  development	  in	  preceding	  decades	  has	  delivered	  a	  materials	  toolbox	  for	  novel	  therapeutic	  
approaches,1,	  2	  imaging	  techniques,3	  and	  sensing	  capabilities,4	  and	  thus	  contributed	  significantly	  to	  
maturation	  of	  biomedicine.1,	  5,	  6	  Depending	  on	  application,	  metals,	  metal	  oxides,	  inorganic	  salts,	  lipids,	  
polymers	  and	  other	  materials	  can	  be	  formulated	  into	  functional	  materials	  with	  sub-­‐micrometer	  
dimensions.	  Of	  these,	  hydrogel	  nanoparticles	  are	  particularly	  attractive	  as	  carriers	  for	  biologically	  fragile	  
cargo7,	  8	  and	  as	  matrices	  for	  creation	  of	  intracellular	  sensors9.	  For	  drug	  delivery,	  a	  unique	  characteristic	  of	  
hydrogels	  is	  their	  capability	  to	  deform	  under	  pressure	  and	  pass	  through	  pores	  with	  dimensions	  narrower	  
than	  the	  nominal	  diameter	  of	  the	  particle.10	  This	  capacity	  is	  reminiscent	  of	  that	  of	  red	  blood	  cells	  and	  may	  
prove	  highly	  important	  in	  the	  context	  of	  depth	  of	  tissue	  penetration	  for	  drug	  carrier	  vehicles.	  Control	  over	  
elasticity	  is	  also	  an	  opportunity	  available	  only	  for	  hydrogel	  biomaterials,	  as	  is	  well	  celebrated	  for	  
macroscopic	  biomaterials	  and	  established	  as	  a	  powerful	  tool	  to	  control	  adhesion,	  proliferation,	  and	  
differentiation	  of	  mammalian	  cells.	  11,	  12	  	  Early	  results	  reveal	  that	  particle	  softness	  allows	  controlling	  the	  
mechanism	  of	  cellular	  entry	  13	  and	  thus	  delivers	  opportunities	  in	  defining	  intracellular	  trafficking	  of	  
nanoparticles.	  For	  intracellular	  biosensors,9	  hydrogels	  are	  stand-­‐alone	  candidate	  materials	  in	  that	  these	  
highly	  swollen	  materials	  allow	  facile	  diffusion	  of	  solutes	  and	  analytes	  thus	  contributing	  to	  the	  performance	  
of	  these	  artificial	  reporter	  organelles.	  Nevertheless,	  despite	  the	  above	  mentioned	  benefits,	  these	  
opportunities	  currently	  receive	  only	  a	  modest	  research	  attention,	  both	  in	  fundamental	  and	  applied	  
aspects.7,	  8	  Two	  factors	  which	  are	  poised	  to	  facilitate	  acceptance	  of	  HNP	  as	  a	  tool	  of	  biomedicine	  are	  i)	  
development	  of	  facile	  techniques	  for	  assembly	  of	  HNP	  and	  ii)	  assembly	  of	  HNP	  using	  polymers	  with	  
acceptable	  level	  of	  biocompatibility	  and	  regulatory	  approval	  for	  advanced	  biomedical	  characterization.	  
With	  this	  in	  mind,	  we	  aimed	  to	  establish	  production	  of	  HNP	  based	  on	  physical	  hydrogels	  of	  poly(vinyl	  
alcohol),	  PVA,	  a	  polymer	  with	  decades	  of	  biomedical	  prominence	  14,	  15	  and	  FDA	  approval	  for	  the	  use	  in	  
humans,	  16	  specifically	  in	  a	  form	  of	  embolic	  bodies	  17.	  While	  microparticles	  17	  and	  macroscopic	  gels	  15	  18	  of	  
PVA	  are	  well	  characterized,	  examples	  of	  nanoparticles	  are	  solitary.	  19-­‐21	  With	  that,	  successful	  history	  of	  use	  
in	  biomedicine	  strongly	  suggests	  that	  HNP	  based	  on	  PVA	  will	  prove	  useful	  as	  drug	  carriers	  and	  vessels	  of	  
biosensors.	  	  
Assembly	  of	  PVA	  HNP	  has	  previously	  been	  accomplished	  via	  emulsion	  –	  cryogelation	  approach,19	  and	  ultra-­‐
high	  pressure	  treatment	  of	  PVA	  solutions.22,	  23	  These	  two	  techniques	  are	  successful	  in	  their	  own	  right	  but	  
leave	  much	  room	  for	  improvement,	  specifically	  with	  regard	  to	  accessibility	  of	  instrumentation	  (high	  
pressure	  treatment)	  or	  uniformity	  of	  particles	  and	  control	  over	  their	  size	  (emulsion	  based	  approach).	  In	  our	  
recent	  work,	  we	  accomplished	  assembly	  of	  PVA	  HNP	  via	  liposomal	  templating,	  i.e.	  producing	  nanoscopic	  
“droplets”	  of	  polymer	  solution	  inside	  liposomes	  with	  subsequent	  hydrogelation	  to	  afford	  particle-­‐shaped	  
hydrogels.REF	  Typically,	  liposomal	  templating	  is	  used	  to	  induce	  hydrogelation	  inside	  liposomal	  voids.	  24,	  25	  
As	  a	  facile	  alternative,	  we	  used	  liposomes	  to	  produce	  polymer	  nanoparticles	  with	  subsequent	  removal	  of	  
the	  lipids	  and	  hydrogelation	  of	  lipid-­‐free	  formulations.	  Assembled	  PVA	  HNP	  revealed	  excellent	  colloidal	  
stability	  and	  a	  remarkable	  stealth-­‐like	  behaviour,	  i.e.	  lack	  of	  interaction	  and	  internalization	  by	  mammalian	  
cells,	  making	  these	  colloidal	  hydrogels	  promising	  as	  long-­‐circulating	  carriers	  for	  diverse	  biomedical	  
applications.	  However,	  liposomal	  templating	  and	  specifically,	  production	  of	  the	  liposomes	  via	  extrusion,	  
exerts	  significant	  practical	  limitations	  on	  assembly	  of	  PVA	  HNP	  through	  this	  technique.	  In	  particular,	  
encapsulation	  efficiency	  of	  the	  polymer	  into	  liposomes	  is	  arrestingly	  low,	  overall	  majority	  of	  the	  polymer	  
chains	  are	  not	  incorporated	  into	  the	  liposomes,	  and	  only	  a	  minor	  fraction	  of	  the	  polymer	  sample	  is	  
recovered	  in	  the	  form	  of	  nanoparticles.	  Further	  to	  this,	  increasing	  viscosity	  of	  polymer	  solutions	  makes	  
extrusion	  impractical	  and	  only	  low	  molecular	  samples	  and	  /	  or	  dilute	  polymer	  solutions	  can	  be	  successfully	  
employed.	  Polymer	  molecular	  weight	  is	  a	  characteristic	  decisive	  in	  diverse	  properties	  of	  biomaterials	  and	  
specifically	  for	  PVA,	  we	  have	  shown	  that	  physical	  hydrogels	  derived	  thereof	  exhibit	  markedly	  differed	  
elasticity	  when	  prepared	  using	  polymer	  samples	  with	  varied	  molecular	  weights.	  26,	  27	  Furthermore,	  in	  our	  
recent	  report	  we	  have	  used	  molecular	  weight	  of	  PVA	  as	  a	  tool	  of	  effective	  control	  over	  spontaneous	  
degradation	  of	  physical	  hydrogels	  in	  physiological	  conditions.28	  Finally,	  retention	  and	  elimination	  of	  PVA	  
from	  the	  human	  body	  is	  to	  large	  extent	  controlled	  by	  the	  polymer	  molecular	  weight.	  29	  Thus,	  it	  is	  imperative	  
to	  identify	  a	  technique	  for	  production	  of	  PVA	  HNP	  which	  affords	  uniform	  nanoparticles	  with	  control	  over	  
particles	  size	  and	  accommodating	  polymer	  samples	  over	  a	  wide	  range	  of	  molecular	  weights.	  
In	  this	  work,	  in	  pursuit	  of	  a	  scalable	  technique	  satisfying	  the	  above	  mentioned	  criteria,	  we	  turned	  to	  
nanoprecipitation.	  Success	  of	  this	  tool	  is	  verified	  by	  its	  commercial	  development,	  specifically	  for	  assembly	  
of	  nanoparticles	  using	  organic	  polymers	  for	  drug	  delivery	  and	  vaccination	  applications.30	  We	  hypothesized	  
that	  nanoprecipitation	  can	  be	  used	  to	  formulate	  PVA	  into	  nanoparticles,	  thus	  taking	  advantage	  over	  arms	  
of	  control	  made	  available	  by	  this	  technique;	  resulting	  nanoparticles	  can	  be	  subsequently	  hydrogelated	  to	  
form	  HNP	  using	  a	  suit	  of	  techniques	  for	  chemical	  and/or	  physical	  crosslinking	  of	  PVA.	  Herein,	  we	  investigate	  
opportunities	  associated	  with	  nanoprecipitation	  with	  regard	  to	  production	  of	  PVA	  nanoparticles	  and	  HNP	  
formulations.	  	  
From	  a	  different	  perspective,	  formulated	  as	  nanomaterials,	  hydrogels	  become	  a	  subject	  for	  investigation	  
within	  the	  field	  of	  nanotoxicology.5	  Microscopic	  and	  macroscopic	  gels	  are	  among	  the	  most	  biocompatible	  
materials,	  31,	  32	  	  a	  notion	  which	  has	  been	  verified	  by	  their	  utility	  in	  tissue	  engineering	  and	  as	  implantable	  
biomaterials.	  In	  contrast,	  biocompatibility	  of	  hydrogel	  nanoparticles	  is	  typically	  confirmed	  only	  through	  
viability	  assays	  in	  cell	  cultures	  and	  as	  such	  knowledge	  on	  the	  subject	  remains	  rather	  cursory.	  It	  is	  now	  
understood	  that	  biocompatible	  polymers	  such	  as	  poly(vinyl	  pyrrolidone),	  poly(hydroxypropyl	  
methacrylamide),	  and	  pluronics	  may	  elicit	  (undesired)	  intracellular	  effect	  once	  internalized	  by	  cells.33	  This	  
includes	  interference	  with	  the	  performance	  of	  intracellular	  enzymes	  (Pgp),	  activation	  of	  nuclear	  
transcription	  factors	  (NF-­‐kB)	  and	  caspases,	  etc.33	  This	  notion	  highlights	  utmost	  importance	  of	  biomedical	  
characterization	  of	  nanomaterials	  extending	  beyond	  simple	  proliferation	  kits.	  Specifically,	  monitoring	  
inflammatory	  responses	  mediated	  by	  nanomaterials	  is	  of	  particular	  interest.	  5	  	  The	  second	  aim	  of	  this	  work	  
was	  therefore	  to	  provide	  an	  initial	  insight	  into	  possible	  intracellular	  effects	  elicited	  by	  the	  internalized	  PVA	  
HNP.	  	  	  
EXPERIMENTAL	  SECTION	  :	  
Materials.	  All	  chemicals,	  if	  not	  noted	  otherwise	  were	  purchased	  from	  Sigma-­‐Aldrich	  and	  used	  as	  received.	  
Commercial	  PVA	  of	  varying	  molecular	  weights	  13-­‐23	  kDa,	  89	  kDa,	  and	  190	  kDa	  are	  denoted	  in	  this	  work	  as	  
low	  (LMW),	  medium	  (MMW)	  and	  high	  (HMW)	  molecular	  weight,	  respectively.	  Poly(vinyl	  alcohol-­‐block-­‐vinyl	  
pyrrolidone)	  ,	  PVA-­‐b-­‐PVP,	  was	  synthesized	  via	  RAFT	  polymerization	  as	  described	  in	  details	  previously.REF	  	  
Mammalian	  cell	  lines	  Hep	  G2	  and	  RAW	  264.7	  were	  routinely	  maintained	  in	  Minimum	  Essential	  Medium	  
Eagle	  (MEME,	  supplemented	  with	  Fetal	  Bovine	  Serum	  (FBS,	  10%),	  penicillin	  streptomycin	  (P/S,	  1%),	  Non-­‐
Essential	  Amino	  Acids	  (NEA,	  1%),	  and	  L-­‐Glutamine	  (2	  mM))	  and	  Dulbecco’s	  Modified	  Eagle’s	  Medium	  
(DMEM,	  supplemented	  with	  FBS	  (10%)	  and	  P/S	  (1%)).	  Cells	  were	  cultured	  in	  at	  37°C	  in	  a	  5%	  CO2	  
atmosphere.	  	  
Methods.	  Dynamic	  light	  scattering	  was	  performed	  on	  a	  Zetasizer	  Nano	  S90,	  Malvern.	  Flow	  cytometry	  was	  
conducted	  on	  an	  BD	  Accuri	  C6	  instrument	  using	  an	  excitation	  wavelength	  of	  488	  nm	  and	  analysing	  at	  least	  
1000	  events	  in	  each	  sample.	  Particles	  and	  cells	  were	  imaged	  on	  a	  Zeiss	  Axio	  Observer	  Z1	  fluorescence	  
microscope.	  Absorbance	  and	  fluorescence	  measurements	  were	  conducted	  using	  an	  EnSpire	  Perkin	  Elmer	  
plate	  reader.	  High-­‐purity	  water	  with	  a	  resistivity	  of	  18.2	  MΩ/cm	  was	  obtained	  from	  a	  Milli	  Q	  Direct	  8	  water	  
purification	  system.	  
For	  SEM	  imaging,	  samples	  were	  mounted	  by	  adhering	  to	  the	  surface	  of	  aluminium	  stubs	  (Agar	  Scientific,	  
Stanstead,	  UK)	  using	  double	  sided	  carbon	  tabs	  (Plano	  GmbH	  Wetzlar,	  Germany).	  Prior	  to	  imaging,	  the	  
specimens	  were	  sputter	  coated	  with	  a	  conductive	  layer	  of	  Gold/Palladium	  in	  a	  Quorum	  SC7620	  mini	  sputter	  
coater	  (Quorum	  Technologies	  Ltd,	  Ashford,	  UK).	  Samples	  were	  then	  loaded	  and	  imaged	  in	  a	  FEI	  Versa3D	  
SEM	  (FEI,	  Hillsboro,	  OR,	  USA)	  fitted	  with	  a	  field	  emission	  gun	  and	  operated	  at	  an	  accelerating	  voltage	  of	  2.0	  
kV.	  Images	  were	  acquired	  digitally	  with	  3072×2207	  pixels	  and	  a	  10	  µsec	  dwell	  time.	  
	  
Assembly	  of	  PVA	  hydrogel	  nanoparticles.	  Nanoprecipitation	  was	  conducted	  using	  polymers	  with	  different	  
molecular	  weight	  (LMW,	  MMW,	  HMW)	  and	  solutions	  with	  polymer	  concentrations	  ranging	  from	  0.25	  g/L	  –	  
20	  g/L).	  In	  a	  typical	  experiment,	  100	  µL	  of	  a	  5	  g/L	  solution	  of	  PVA	  and	  containing	  0.1	  g/L	  PVA-­‐b-­‐PVP	  was	  
added	  dropwise	  to	  2	  mL	  ethanol	  (EtOH)	  under	  continuous	  magnetic	  stirring	  (150-­‐200	  rpm).	  Resulting	  
nanoparticles	  were	  isolated	  via	  centrifugation	  (10,000	  rpm,	  -­‐9°C,	  10	  minutes).	  Hydrogelation	  was	  
accomplished	  via	  incubation	  of	  the	  nanoparticles	  in	  50	  µL	  40	  v/v%	  aq.	  ethanol	  overnight.	  PVA	  HNPs	  were	  
then	  isolated	  via	  centrifugation	  to	  facilitate	  which	  suspensions	  were	  supplemented	  with	  excess	  ethanol	  
(10,000	  rpm,	  -­‐9°C,	  30	  minutes).	  The	  HNPs	  were	  dispersed	  in	  PBS	  prior	  to	  use	  or	  in	  MQ	  when	  freeze	  drying	  
was	  applied.	  Assembly	  of	  PVA	  HNP	  cell	  culture	  experiments	  was	  conducted	  according	  to	  the	  protocol	  
outlined	  above	  and	  using	  solutions	  of	  PVA	  supplemented	  with	  collagen	  and	  PVA-­‐FITC	  to	  final	  
concentrations	  of	  0.1	  g/L	  and	  1	  g/L,	  respectively.	  	  
Cellular	  uptake,	  cytotoxicity,	  and	  nitric	  oxide	  studies.	  For	  cellular	  uptake	  studies	  Hep	  G2	  and	  RAW	  264.7	  
cells	  were	  plated	  in	  a	  96	  well	  plate	  (2.5	  ×	  104	  cells/well	  and	  1.5	  ×	  104	  cells/well	  for	  respective	  cell	  types)	  and	  
allowed	  to	  adhere	  overnight	  in	  medium.	  PVA	  HNPs	  (dispersed	  in	  PBS	  and	  diluted	  with	  media,	  10	  and	  50	  
µg/well)	  prepared	  as	  described	  above	  containing	  1	  g/L	  PVA-­‐FITC	  and	  0.1	  g/L	  collagen	  were	  incubated	  with	  
the	  cells	  for	  24	  hours	  at	  37°C	  and	  5%	  CO2.	  For	  analysis	  the	  cells	  were	  trypsinized	  with	  0.5%	  trypsin	  and	  PVA	  
HNP	  internalization	  of	  the	  harvested	  cells	  was	  assessed	  via	  flow	  cytometry	  using	  an	  excitation	  wavelength	  
of	  530	  nm.	  For	  each	  experiment,	  1000	  events	  were	  studied	  on	  the	  flow	  cytometer	  	  
For	  cytotoxicity	  measurements	  of	  Hep	  G2	  the	  cells	  were	  seeded	  in	  a	  96	  well	  plate	  (2.5	  ×	  104	  cells/well)	  for	  
24	  hrs.	  PVA	  HNPs	  containing	  0.1	  g/L	  collagen	  (30	  µg/well)	  were	  incubated	  with	  the	  cells	  for	  another	  24	  
hours,	  before	  a	  PrestoBlue	  test	  following	  manufacturer’s	  instructions	  was	  performed.	  
Cytotoxicity	  and	  relative	  nitric	  oxide	  (NO)	  levels	  in	  RAW	  264.7	  cells	  were	  assessed	  simultaneously.	  The	  cells	  
were	  seeded	  in	  a	  96	  well	  plate	  (1.5	  ×	  104	  cells/well)	  overnight	  and	  subsequently	  incubated	  with	  PVA	  HNPs	  
(25	  µg	  pr	  well)	  or	  PVA	  solutions	  (10	  µL	  2.5	  g/L).	  After	  24	  hours,	  media	  was	  replaced	  with	  90	  µL	  phenol	  red	  
free	  complete	  DMEM	  media	  and	  10	  µL	  reagent	  (1	  µg/mL	  lipopolysaccharide	  (LPS	  E.coli	  026:B6)).	  Cells	  were	  
incubated	  with	  L-­‐NG-­‐nitroarginine	  methyl	  ester	  (L-­‐NAME),	  dimethyl	  sulfoxide	  (DMSO),	  PBS	  and	  only	  LPS	  as	  
controls.	  After	  another	  24	  hours,	  a	  Griess	  assay	  34	  was	  conducted	  on	  50	  µL	  media	  and	  on	  a	  2	  fold	  serial	  
dilution	  of	  sodium	  nitrite	  (100	  –	  1.56	  µM	  in	  MQ)	  used	  to	  quantify	  nitrite	  levels.	  To	  start	  the	  reaction,	  50	  µL	  
reagent	  B	  (10	  g/L	  sulfanilic	  acid	  in	  5%	  phosphoric	  acid)	  was	  added	  to	  the	  samples	  after	  5	  minutes	  50	  µL	  
reagent	  A	  (1	  g/L	  N-­‐1-­‐napthylethylenediamine	  dihydrochloride	  in	  MQ)	  was	  added.	  The	  absorbance	  of	  the	  
samples	  and	  the	  serial	  diluted	  sodium	  nitrite	  were	  measured	  on	  a	  plate	  reader	  after	  additionally	  5	  minutes	  
at	  548	  nm.	  The	  results	  of	  the	  PVA-­‐	  HNPs	  or	  solutions	  were	  normalized	  to	  the	  negative	  control,	  incubation	  
with	  LPS,	  and	  reflects	  the	  relative	  NO	  levels.	  For	  the	  cytotoxicity	  test	  remaining	  media	  was	  removed	  from	  
the	  cells	  and	  a	  PrestoBlue	  test	  was	  performed.	  
Cell	  fixation	  and	  staining.	  For	  visualization	  of	  internalized	  PVA	  HNP	  assembled	  by	  the	  nanoprecipitation	  
method,	  Hep	  G2	  and	  RAW	  264.7	  cells	  were	  fixed	  on	  glass	  slides.	  The	  glass	  slides	  were	  incubated	  with	  1	  mL	  
of	  1	  g/L	  PLL	  in	  PBS	  for	  1	  hour	  prior	  to	  cell	  addition	  to	  make	  the	  slides	  cell	  adhesive.	  Hep	  G2	  and	  RAW	  264.7	  
cells	  were	  seeded	  onto	  the	  slides	  (5	  ×	  104	  and	  1	  ×	  105	  cells/well,	  respectively)	  in	  a	  12	  well	  plate.	  The	  cells	  
were	  left	  to	  adhere	  for	  24	  hours	  at	  37°C	  and	  5%	  CO2.	  HNP	  containing	  PVA-­‐FITC	  and	  0.1	  g/L	  collagen	  
(dispersed	  in	  PBS	  and	  diluted	  with	  media,	  ca.	  150	  µg/well)	  were	  added	  and	  incubated	  with	  the	  cells	  for	  24	  
hours.	  The	  cells	  were	  fixed	  with	  ethanol.	  In	  short	  media	  was	  replaced	  with	  1	  mL	  of	  a	  cold	  95:5	  
ethanol:glacial	  acetic	  acid	  mixture	  for	  10	  minutes.	  The	  glass	  slides	  were	  washed	  with	  PBS	  three	  times	  
before	  addition	  of	  0.5	  mL	  DAPI	  (100	  ng/mL)	  stain	  for	  30	  minutes.	  The	  slides	  were	  washed	  additionally	  three	  
times	  with	  PBS	  before	  visualization	  under	  the	  microscope.	  	   	  
RESULTS	  AND	  DISCUSSION	  
Nanoprecipitation	  method	  was	  originally	  patented	  by	  Fessi	  et	  al.35	  This	  patent	   includes	  several	  guidelines	  
for	  preparing	  polymer	  NPs,	  one	  being	  that	  the	  polymer	  concentration	  in	  the	  solvent	  should	  vary	  between	  
0.1	   and	   10%	   and	   preferably	   between	   0.2	   and	   2%	   by	   weight.	   Following	   this	   and	   the	   methods	   used	   by	  
others,36-­‐38	   nanoprecipitation	   of	   PVA	  was	   examined	   using	   aqueous	   solutions	  with	   polymer	   concentration	  
ranging	   from	  0.25	   to	  20	  g/L	   and	  using	   lower	  aliphatic	   alcohols	   as	  non-­‐solvents.	  Receiving	   solutions	  were	  
supplemented	  with	  custom	  made	  block	  copolymer	  of	  PVA	  with	  poly(vinyl	  pyrrolidone),	  PVA-­‐b-­‐PVP,	  which	  
was	  necessary	  to	  ensure	  colloidal	  stability	  of	  the	  formed	  nanoparticles.REF	  In	  preliminary	  experiments,	  we	  
found	   that	   ethanol	   and	   isopropanol	   are	  equally	   effective	   in	  precipitating	  PVA	   from	   its	   aqueous	   solutions	  
and	   resulting	   nanoparticles	   showed	   a	   decreased	   tendency	   to	   aggregate	   in	   ethanol;	   for	   this	   reason,	   in	  
subsequent	   experiments	   nanoprecipitation	  was	   performed	   using	   EtOH	   as	   a	   polymer-­‐coagulating	   solvent.	  
Nanoprecipitation	  was	  performed	  using	  scintillation	  vials	  with	  2	  mL	  ethanol	  as	  a	  receiving	  solution	  in	  which	  
case	  as	  much	  as	  200	  µL	  aqueous	  polymer	  solution	  could	  be	   introduced	  drop-­‐wise	  without	  compromising	  
success	  of	  technique	  (see	  Supporting	  Information,	  Figure	  S1).	  
Commercial	   samples	   of	   PVA	   used	   in	   this	  
work	  had	  molecular	  weights	  of	  13-­‐23	  kDa,	  
89	   kDa,	   and	   190	   kDa,	   here	   and	   below	  
denoted	   as	   low	   (LMW),	   medium	   (MMW)	  
and	   high	   (HMW)	   molecular	   weight,	  
respectively.	   For	   each	   polymer	   molecular	  
weight,	   there	   existed	   an	   upper	   limit	   in	  
concentration	   above	   which	  
nanoprecipitation	   did	   not	   yield	  
nanoparticles	   but	   afforded	   powders,	  
fibrils,	   or	   other	   macroscopic	   polymer	  
aggregates,	  Figure	  1.	  Thus,	   for	  HMW	  PVA,	  
nanoparticles	   were	   obtained	   using	  
polymer	  solutions	  with	  concentrations	  not	  
exceeding	  5	  g/L.	  With	  decreasing	  polymer	  
molecular	   weight,	   progressively	   higher	  
concentrations	  of	  polymer	   solutions	  could	  
be	   used	   for	   production	   of	   nanoparticles	  
and	  for	  medium	  and	  low	  molecular	  weight	  samples,	  at	  least	  20	  and	  10	  g/L	  concentrations	  respectively	  were	  
suitable	   for	   polymer	   nanoprecipitation.	   Within	   the	   defined	   range	   of	   polymer	   concentrations,	   polymer	  
content	  in	  the	  solution	  used	  for	  nanoprecipitation	  proved	  to	  be	  a	  powerful	  tool	  of	  control	  over	  the	  size	  of	  
assembled	   nanoparticles.	   This	   notion	   is	   best	   illustrated	   on	   LMW	   PVA.	   With	   decreasing	   polymer	  
concentration,	   from	   20	   to	   1	   g/L,	   nanoprecipitation	   yielded	   nanoparticles	   with	   progressively	   decreasing	  
sizes,	  from	  300	  nm	  in	  the	  case	  of	  the	  highest	  polymer	  concentration,	  to	  ca.	  200	  nm	  assembled	  with	  the	  use	  
of	   10	   g/L	   polymer	   solution,	   and	   below	   100	   nm	   for	   1	   g/L	   polymer	   solution.	   Diluting	   the	   polymer	   to	  
concentrations	  below	  1	  g/L	  did	  not	  afford	  a	  decrease	  in	  particle	  size.	  Presented	  results	  are	  based	  on	  at	  least	  
3	  independent	  experiments	  and	  illustrate	  good	  reproducibility	  of	  the	  technique.	  	  
Figure	   1:	   Size	   of	   PVA	   NPs	   in	   EtOH	   after	   dropwise	   addition	   of	   100	   µL	  LMW,	  MMW,	  and	  HMW	  PVA	  solutions	  of	  varied	  concentrations	  (0.25	  –	  20	  g	  L-­‐1)	  containing	  0.1	  g	  L-­‐1	  PVA-­‐b-­‐PVP	  into	  2	  mL	  EtOH,	  n	  =	  3.	  *	  P<0.05,	  **	  P<0.01,	  ***	  P<0.001.	  
	  Synthesized	  nanoparticles	  were	  collected	  via	  centrifugation	  with	  typical	  values	  of	  overall	  polymer	  recovery	  
of	  XX	  %.	  Assembled	  nanoparticles	  could	  be	  stored	  for	  
extended	  periods	  of	   time	  without	  noticeable	   signs	  of	  
aging	  or	  aggregation	  and	  could	  be	  readily	  re-­‐dispersed	  
in	   ethanol	   to	   yield	   suspensions	   with	   near	   identical	  
average	   size	  as	   freshly	  prepared	   samples.	   Samples	  of	  
NP	   prepared	   using	   5	   g/L	   polymer	   solutions	   were	  
imaged	  using	  scanning	  electron	  microscopy,	  Figure	  2,	  
which	   confirmed	   assembly	   and	   isolation	   of	   spherical,	  
non-­‐porous	   particles	   with	   sizes	   corresponding	   to	   the	  
values	   established	   using	   dynamic	   light	   scattering.	  
Above	   experiments	   demonstrate	   that	  
nanoprecipitation	   is	   a	   facile	   technique	   to	   assemble	  
nanoparticles	   based	   on	   PVA	   with	   polymer	   molecular	  
weight	   varied	   in	   a	  wide	   range,	   from	   ~	   13-­‐23	   to	   146-­‐
186	   kDa,	   and	   using	   solutions	   in	   a	   wide	   range	   of	  
polymer	   content.	   These	   aspects	   make	  
nanoprecipitation	   advantaged	   over	   e.g.	   liposomal	  
templating	   in	   that	   the	   latter	   cannot	   accommodate	  
polymer	   solutions	   with	   high	   viscosityREF	   which	   sets	   the	   limit	   on	   utility	   of	   the	   latter	   technique	   to	   low	  
polymer	  molecular	  weights	  and	  dilute	  polymer	  solutions.	  Compared	  to	  “ultra-­‐high	  pressure”	   treatment,23	  
nanoprecipitation	   does	   not	   require	   specialized	   equipment.	   In	   contrast	   to	   emulsion	   based	   techniques,19	  
above	  developed	  approach	  relies	  on	  mild,	  non-­‐denaturing	  organic	  solvents	  and	  does	  not	  employ	  high	  shear	  
stresses.	  All	  of	  the	  above	  speaks	  towards	  practical	  utility	  of	  nanoprecipitation	  as	  a	  method	  of	  production	  of	  
HNP,	  specifically	  those	  based	  on	  PVA.	  	  
As	  prepared	  via	  precipitation	  into	  alcohol	  solutions,	  PVA	  nanoparticles	  dissolve	  upon	  contact	  with	  water	  or	  
aqueous	   buffered	   solutions	   thus	   revealing	   insufficient	   interpolymer	   binding,	   i.e.	   lack	   of	   physical	  
hydrogelation.	   Previously,	   we	   showed	   that	   PVA	   hydrogelation	   can	   be	   induced	   via	   a	   number	   of	   non-­‐
cryogenic	  techniques,27	  specifically	  through	  incubation	  in	  mixtures	  of	  water	  with	  isopropanol.	  27+PARTICLE	  
We	   revealed	   that	   pure	   water	   and	   neat	   IPA	   afford	   no	   hydrogels	   and	   PVA	   samples	   (micro-­‐structured,	  
micrometer	   thick	   surface	   adhered	   films)	   dissolved	   upon	   contact	   with	   phosphate	   buffered	   saline.	   In	  
contrast,	  water	  –	   isopropanol	  mixtures	  with	  40	  vol	  %	  content	  of	  water	  elicited	  hydrogelation	  of	  PVA	  and	  
yielded	  robust	  hydrogel	  samples	  which	  remained	  stable	  over	  at	  least	  24	  h	  incubation	  in	  physiological	  media	  
at	  37	  C.	  
Figure	  2.	  Size	   of	  5	  g	  L-­‐1	   LMW	   (A-­‐B),	  MMW	  (C)	  and	  HMW	  (D)	  PVA	  NPs,	  scale	  bars	  are	  1µm	  (A)	  and	  200	  nm	  (B-­‐D)2.	  
In	  this	  work,	  we	  investigated	  if	  similar	  effect	  
can	  be	  exerted	  onto	  PVA	  NP	  and	  used	  water	  
–	  ethanol	  mixtures	  with	  60	  vol	  %	  content	  of	  
alcohol.	   Preparations	   of	   PVA	   NP	   were	  
incubated	  in	  water-­‐alcohol	  mixture	  for	  24	  h	  
upon	  which	  resulting	  hydrogel	  nanoparticles	  
were	   isolated	   via	   centrifugation.	   Prepared	  
samples	   were	   directly	   redispersed	   in	   PBS	  
and	   analysed	   using	   DLS	   and	   zeta	   potential	  
measurements,	  Figure	  3.	  
For	   each	   of	   the	   three	   PVA	   molecular	  
weights	   (L,	   M,	   and	   H),	   HNP	   exhibited	  
polydispersity	   indexes	   of	   <	   0.2	   revealing	  
that	   nanoprecipitation	   and	   non-­‐cryogenic	  
hydrogelation	   afforded	   well-­‐defined	  
colloidal	  carriers.	  Hydrodynamic	  radii	  of	  the	  
HNP	   were	   larger	   than	   those	   of	   the	   parent	  
PVA	   NP	   which	   is	   readily	   explained	   by	  
characteristic	  hydrogel	   swelling	   (c.f.	  data	   in	  
Figure	   1	   and	   3).	   This	   effect	   was	   most	  
pronounced	   for	   LMW	   sample	   and	   only	  
minor	   for	   HMW	   plausibly	   revealing	   higher	  
degree	   of	   crosslinking	   for	   the	   latter.	   For	  
each	   molecular	   weight,	   HNP	   exhibited	   a	  
near-­‐zero	   zeta	   potential,	   as	   would	   be	  
expected	   for	   nanoparticles	   comprised	   of	  
this	   non-­‐ionic	   polymer.	   Despite	   this,	   particles	   remained	   colloidally	   stable	   and	   revealed	   no	   tendency	   to	  
aggregation.	  
For	   cell	   culture	   experiments,	   PVA	   NHP	   were	   prepared	   using	   a	   mixture	   of	   PVA	   with	   collagen,	   a	   natural	  
protein	   with	   pro-­‐cell	   adhesive	   properties.	   PVA	   hydrogels	   have	   well-­‐documented	   low	   cell	   adhesive	  
properties.	   In	  contrast,	  hydrogels	  prepared	  using	  blends	  of	  PVA	  with	  collagen	  (as	  well	  as	  chitosan,	  poly-­‐L-­‐
lysine,	   etc)	   support	   cell	   adhesion	   and	   proliferation.	   27	   We	   aimed	   to	   apply	   this	   facile	   materials	   design	  
strategy	  to	  hydrogel	  nanoparticles	  and	  in	  assembly	  of	  HNP	  used	  solutions	  of	  PVA	  containing	  collagen	  at	  a	  
0.1	  g/L	  concentration.	  For	  each	  PVA	  molecular	  weight,	  collagen-­‐containing	  HNP	  exhibited	  a	  size	  similar	  to	  
pristine,	  PVA-­‐only	  counterparts,	  polydispersity	  indeces	  at	  or	  below	  0.3,	  and	  near	  zero	  zeta	  potential	  (Figure	  
3).	  In	  other	  words,	  addition	  of	  collagen	  appears	  to	  have	  a	  negligible	  effect	  on	  the	  assembly	  of	  HNP	  and	  the	  
properties	  of	  resulting	  preparation,	  specifically	  size	  and	  zeta	  potential.	  	  
Figure	  3.	  Hydrodynamic	  diameter,	  polydispersity	  (PDI),	  and	  zeta-­‐potential	   (ZP)	   of	   PVA	   hydrogel	   nanoparticles	   prepared	   via	  nanoprecipitation	   and	   hydrogelation	   in	   aqueous	   ethanol.	   PVA	  HNP	  were	  prepared	  using	  5	  g	  L-­‐1	  solutions	  of	  polymers	  optionally	  supplemented	   with	   collagen	   to	   0.1	   g/L.	   Presented	   results	   are	  average	   of	   at	   least	   three	   independent	   experiments	   and	   reported	  as	  mean	  ±	  standard	  deviation.	  
	  
Visualization	   of	   HNP	   was	   performed	   using	  
fluorescence	   microscopy	   (FM)	   and	   scanning	   electron	  
microscopy	   in	   PBS	   suspension	   and	   dry	   state,	  
respectively,	   Figure	   4.	   For	   FM,	   samples	   of	   HNP	  were	  
prepared	   using	   commercial	   PVA	   mixed	   with	   custom	  
made,	  fluorescently	  labelled	  PVA.	  For	  the	  latter,	  RAFT-­‐
derived,	   amine-­‐terminated	   PVA	   was	   reacted	   with	  
fluorescein	   isothiocyanate	   and	   purified	   via	  
precipitation	  into	  methanol,	  39	  as	  described	  in	  detail	  in	  
the	   Experimental	   Section.	   Resulting	   preparation	   of	  
HNP	   revealed	   excellent	   colloidal	   stability	   and	  
presented	   FM	   image	   confirms	   the	   expected	   size	   of	  
HNP.	  SEM	  observations	  were	  also	  consistent	  with	  sub-­‐
micrometer	   sized	   nanoparticles.	   Visual	   observation	  
suggests	   that	   sizes	   of	   the	   particles	   in	   the	   SEM	  
micrographs	   are	   lower	   than	   the	   values	   presented	   in	  
Fig	  3,	  which	   is	   readily	  explained	  by	  HNP	  dehydration	  
during	   preparation	   of	   the	   samples	   of	   electron	  
microscopy.	  
With	   an	   overall	   aim	   of	   this	   research	   focused	   on	   the	   assembly	   of	   colloidal	   drug	   carriers	   and	   hepatic	  
applications,	   we	   next	   examined	   interaction	   of	   PVA	   HNP	   with	   cells	   belonging	   to	   lineages	   with	   hepatic	  
relevance,	   namely	  hepatocytes	   (HepG2)	   and	  macrophages	   (RAW	  264.7).	   For	   these	  experiments,	   colloidal	  
hydrogels	   were	   prepared	   using	   mixtures	   of	   commercial	   PVA	   with	   custom	   made,	   fluorescently	   labelled	  
polymer.	  Following	  24	  h	  incubation	  of	  cells	  with	  HNP,	  analysis	  of	  harvested	  cells	  was	  performed	  using	  flow	  
cytometry.	   In	   this	   read	   out,	   increase	   in	   cells	   fluorescence	   signifies	   association	   and/or	   internalization	   of	  
particles	  by	   cells.	   For	  hepatocytes,	  24	  h	   incubation	  with	  PVA	  HNP	   led	   to	  an	   insignificant	   increase	   in	   cells	  
fluorescence	  and	  histogram	  of	  distribution	  of	  cells	  fluorescence	  is	  similar	  to	  that	  obtained	  for	  pristine,	  non-­‐
treated	  cells,	  Figure	  5,A.	  In	  contrast,	  analysis	  of	  cells	  following	  incubation	  with	  hydrogel	  particles	  prepared	  
using	  mixtures	   of	   PVA	  with	   collagen	   exhibits	   a	   noticeable	   shift	   in	   the	   histogram	   suggesting	   pronounced	  
interaction	   of	   the	   cells	   with	   PVA	   HNP.	   For	   macrophages	   (Figure	   5,B),	   incubation	   with	   collagen-­‐
functionalized	   PVA	   HNP	   also	   resulted	   in	   a	   significant	   shift	   in	   population	   of	   cells	   to	   higher	   fluorescence	  
values.	  However,	  in	  contrast	  to	  hepatocytes,	  incubation	  with	  pristine	  PVA	  HNP	  was	  also	  accompanied	  with	  
a	  pronounced	   increase	   in	   cells	   fluorescence	   revealing	   that	   for	   these	   cells,	   interaction	  with	  HNP	  does	  not	  
necessitate	  the	  presence	  of	  collagen	   in	  the	  hydrogel	  matrix.	  Figure	  5	  C,D	  presents	  microscopy	   images	  for	  





Figure	   4.	   Fluorescence	   microscopy	   (A)	   and	   SEM	   (B-­‐D)	  images	   of	   PVA	   HNP	   prepared	   using	   5	   g/L	   polymer	  solutions	   and	   samples	   with	   low	   (A,B),	   medium	   (C)	   and	  high	  (D)	  molecular	  weight.	  Scale	  bars	  are	  5µm	  (A)	  and	  200	  nm	  (B-­‐D).	  
	   	  
Experiments	  and	  analyses	  presented	  above	  were	  conducted	  using	  HNP	  prepared	  using	  samples	  of	  PVA	  with	  
varied	  molecular	  weights.	   Experimental	   data	  were	   used	   to	   estimate	   the	   fraction	   of	   cells	   which	   undergo	  
successful	  interaction	  with	  colloidal	  hydrogels,	  Figure	  5	  E,F.	  For	  both	  cell	  lines,	  interaction	  of	  cells	  with	  HNP	  
revealed	  a	  well-­‐pronounced	  dose	  response.	  This	  is	  best	  illustrated	  for	  hepatocytes,	  in	  which	  case	  10	  µg	  per	  
well	   administered	   dose	   afforded	   a	   negligible	   fraction	   of	   cells	   testing	   positive	   for	   the	   associated	   HNP;	   in	  
contrast,	   administration	   of	   50	   µg	   of	   hydrogel	   colloids	   resulted	   in	   significantly	   increased	   levels	   of	   cellular	  
fluorescence	  which	  allowed	  reliable	  analysis	  of	  factors	  governing	  interaction	  of	  HNP	  with	  mammalian	  cells.	  	  
For	   both	   cell	   lines,	   the	   presence	   of	   collagen	   within	   HNP	   facilitated	   interaction	   with	   mammalian	   cells,	  
although	  with	  a	  varied	  degree	  of	  statistical	  significance,	  as	  estimated	  based	  on	  3	  independent	  experiments.	  
A	   further	   important	   observation	   is	   that	   interaction	   of	   HNP	   with	   the	   cells	   is	   largely	   independent	   on	   the	  
molecular	   weight	   of	   the	   polymer	   used	   for	   production	   of	   particles.	  We	   have	   previously	   shown	   that	   PVA	  
physical	  hydrogels	  prepared	  using	  polymer	  samples	  with	  these	  molecular	  weights	  are	  drastically	  different	  in	  
their	   mechanical	   properties.26	   Further	   to	   this,	   quantitative	   data	   on	   polymer	   incorporation	   into	   PVA	  
hydrogels	  revealed	  that	  with	  increased	  molecular	  weight,	  a	  progressively	  higher	  fraction	  of	  polymer	  chains	  
is	   retained	  within	   the	   hydrogel.28	   Thus,	   it	   is	   highly	   likely	   that	   HNP	   as	   used	   in	   this	   study	   are	   significantly	  
differed	  in	  the	  polymer	  content	  and	  plausibly	  softness.	  The	  latter	  parameter	  is	  known	  to	  significantly	  affect	  
behaviour	   of	  mammalian	   cells	   at	   a	   biomaterials	   interface11	   and	   for	   HNP,	  matrix	   elasticity	  was	   shown	   to	  
define	  the	  mechanism	  of	  internalization	  by	  macrophages.13	  Data	  in	  Figure	  6	  illustrate	  that	  within	  the	  range	  
of	  molecular	  weights	   studied	   and	   at	   least	  with	   the	   current	   experimental	   set-­‐up,	   interaction	   of	   PVA	  HNP	  
with	  hepatocytes	  and	  macrophages	  is	  not	  governed	  by	  the	  molecular	  weight	  of	  PVA	  used	  in	  the	  assembly	  of	  
hydrogel	  nanoparticles.	  	  
Previously,	   we	   showed	   that	   interaction	   of	   hepatocytes	   with	   PVA	   HNP	   and	   their	   collagen	   containing	  
counterparts	   resulted	   in	  a	  minor	   if	   any	   change	   in	   the	   rate	  of	   cellular	  proliferation.	   To	  verify	   this	   for	  PVA	  
HNP	   prepared	   via	   nanoprecipitation	   and	   using	   PVA	   with	   differed	   molecular	   weights,	   hepatocytes	   were	  
incubated	  with	  HNP	  over	  24	  h	  and	  viability	  assay	  performed	  thereafter	  revealed	  a	  negligible	  change	  in	  the	  
cells	   viability	   (Figure	   S1),	   thus	   further	   supporting	   the	   benign,	   non-­‐toxic	   nature	   of	   PVA	   HNP	   as	   colloidal	  
carriers	  for	  biomedical	  applications.	  	  
Inasmuch	  as	  macrophages	  and	  specifically	  Kupffer	  cells	  (liver	  resident	  macrophages)	  are	  often	  the	  key	  
players	  in	  eliminating	  nanoparticles	  form	  circulation,	  we	  next	  aimed	  to	  gain	  a	  more	  detailed	  understanding	  
of	  the	  potential	  effects	  associated	  with	  interaction	  of	  PVA	  HNP	  with	  the	  cells	  of	  this	  type.	  An	  added	  
objective	  of	  this	  study	  was	  to	  compare	  effects	  elicited	  by	  polymers	  administered	  as	  solutions	  or	  formulated	  
as	  HNP.	  Further	  to	  a	  rather	  cursory	  viability	  screening,	  we	  monitored	  pro-­‐	  and	  anti-­‐	  inflammatory	  activity	  of	  
PVA,	  specifically	  through	  quantifying	  levels	  of	  nitric	  oxide	  produced	  by	  the	  macrophages.	  NO	  is	  a	  messenger	  
Figure	  5	  A,B:	  Typical	  flow	  cytometry	  histograms	  obtained	  for	  hepatocytes	  (A)	  and	  macrophages	  (B)	  upon	  incubation	  of	  cells	  with	  PVA	  HNP	  for	  24	  h:	  pristine	  cells	  (1),	  cells	  upon	  incubation	  with	  PVA	  HNPs	  (2),	  and	  cells	  upon	  incubation	  with	  collagen-­‐containing	   PVA	   HNP	   (3).	   (C,D)	   Overlay	   of	   differential	   interference	   contrast	   and	   fluorescence	   microscopy	   images	   for	  hepatocytes	   (C)	   and	  macrophages	   (D)	   upon	   their	   incubation	  with	   collagen-­‐containing	   PVA	   HNP	   prepared	   using	   a	   5	   g/L	  solution	  of	  PVA	  with	  medium	  molecular	  weight	  and	  supplemented	  with	  PVA-­‐FITC	  (green);	  cells	  nuclei	  were	  staining	  using	  DAPI	  (blue).	  (E,F)	  Percentage	  of	  cells	  testing	  positive	  for	  fluorescence	  of	  PVA	  HNP	  following	  a	  24	  h	  incubation	  of	  hepatocytes	  (E)	   and	  macrophages	  (F)	  with	  PVA	  HNP.	  Particles	  were	  prepared	  using	   solutions	  of	  PVA	  with	  different	  molecular	  weight	  with	  polymer	  concentration	  of	  5	  g/L	  and	  optionally	  supplemented	  with	  collagen	  to	  0.1	  g	  L-­‐1.	  Presented	  results	  are	  average	  of	  at	  least	  three	  independent	  experiments	  and	  reported	  as	  mean	  ±	  standard	  deviation.*	  P<0.05,	  **	  P<0.01,	  ***	  P<0.001	  
and	  a	  therapeutic	  molecule	  with	  diverse	  functions	  in	  the	  human	  body.	  40-­‐43	  Macrophages	  produce	  NO	  in	  
response	  to	  diverse	  pro-­‐inflammatory	  stimuli,	  such	  as	  viremia,	  bacterial	  contamination,	  etc.	  Macrophages	  
cultured	  on	  biomaterials	  also	  use	  NO	  as	  a	  way	  to	  signal	  inflammation	  and	  thus,	  elicit	  inflammatory	  
response	  as	  implicated	  in	  tissue	  acceptance	  of	  implants.	  44	  All	  of	  the	  above	  makes	  screening	  NO	  levels	  in	  
cultured	  macrophages	  relevant	  to	  diverse	  biomedical	  applications,	  from	  drug	  delivery	  to	  tissue	  engineering.	  	  
PVA	  polymer	  and	  HNP	  were	  added	  at	  matched	  concentrations	  to	  cultured	  macrophages.	  Following	  24	  h	  
incubation,	  cells	  were	  optionally	  stimulated	  by	  bacterial	  lipopolysaccharide,	  a	  potent	  pro-­‐inflammatory	  
agent,	  and	  levels	  of	  NO	  were	  quantified	  using	  Griess’	  reagent	  following	  a	  further	  24	  h	  incubation.	  In	  these	  
experiments,	  level	  of	  NO	  registered	  upon	  stimulation	  of	  macrophages	  in	  absence	  of	  PVA	  was	  set	  to	  100	  %.	  
Un-­‐stimulated	  cells	  produce	  NO	  on	  a	  level	  below	  detection	  limit,	  which	  corresponds	  to	  <10	  %	  on	  the	  above	  
set	  scale.	  	  
Addition	   of	   PVA	   as	   polymer	   solution	   or	  
formulated	  as	  HNP	  alone	  and	  in	  absence	  of	  
LPS	   did	   not	   afford	   increased	   production	   of	  
NO	   and	   for	   all	   cases,	   NO	   levels	   remained	  
below	   the	   level	   of	   reliable	   detection.	  
Possible	   routes	   of	   activation	   of	  
macrophages	   towards	   induced	   production	  
of	  inflammatory	  markers	  include	  interaction	  
with	   receptors	   on	   the	   cell	   surface,	   as	   is	  
documented	   for	   nanoparticles,	   5	   as	  well	   as	  
intracellular	   activation	   of	   nuclear	  
transcription	   factors,	   33	   e.g.	   NF-­‐κB.	   The	  
latter	  phenomenon	   is	  well	   documented	   for	  
pluronics,	   amphiphilic,	   micelle-­‐forming	  
polymers	  with	  diverse	  use	  in	  drug	  delivery33.	  
It	   highly	   relevant	   for	   this	   work	   in	   that	  
activation	   of	   NF-­‐κB	   results	   in	   an	   increased	  
synthesis	  of	   inducible	  nitric	  oxide	  synthase,	  
an	   enzyme	   responsible	   for	   production	   of	  
high	  concentrations	  of	  NO	  by	  macrophages.	  
While	   data	   in	   Figure	   6	   do	   not	   rule	   out	  
activation	   of	   nuclear	   transcription	   factors,	  
this	  dataset	  demonstrates	  that	  PVA	  polymer	  
and	   hydrogel	   nanoparticles	   do	   not	   elicit	  
production	  of	  NO	  indicative	  of	  inflammatory	  
response.	  	  
Un-­‐expectedly	  and	   in	  contrast	  with	  an	  overall	  majority	  of	  nanoparticle	   formulations	  reported	  previously,5	  
administration	   of	   PVA	   HNP	   resulted	   in	   a	   pronounced	   anti-­‐inflammatory	   response.	   Pre-­‐incubation	   of	  
macrophages	  with	  PVA	  HNP	  prior	  to	  stimulation	  with	  LPS	  afforded	  a	  25-­‐40	  %	  reduction	  in	  the	  levels	  of	  NO	  
produced	  by	  stimulated	  macrophages,	  Figure	  X,C.	  Polymer	  solutions	  had	  no	  such	  effect;	  in	  fact,	  levels	  of	  NO	  
Figure	  6.	  (A)	  Levels	  of	  nitric	  oxide	  produced	  by	  macrophages	  upon	  their	   culturing	   in	   the	   presence	   of	   PVA	   administered	   as	   polymer	  solution	   of	   suspension	   of	   HNP.	   (B,C)	   Viability	   and	   levels	   of	   nitric	  oxide	   produced	   by	   the	   macrophages	   upon	   their	   culturing	   in	   the	  presence	  of	  PVA	  administered	  as	  polymer	  solution	  of	  suspension	  of	  HNP	   and	   subsequent	   stimulation	   with	   a	   pro-­‐inflammatory	   agent,	  LPS.	   Presented	   results	   are	   average	   of	   at	   least	   three	   independent	  experiments	  and	  reported	  as	  mean	  ±	  standard	  deviation.*	  P<0.05,	  **	  P<0.01,	  ***	  P<0.001.	  
generated	  by	   stimulated	  macrophages	   following	  pre-­‐incubation	  with	  polymer	   solutions	  were	  higher	   than	  
those	   produced	   by	   pristine	   macrophages,	   albeit	   without	   statistical	   significance	   of	   this	   observation.	   For	  
solutions	  and	  HNP,	  administration	  and	  incubation	  with	  PVA	  resulted	  in	  a	  negligible	  change	  in	  the	  viability	  of	  
cultured	  macrophages.	  At	  the	  same	  time,	  for	  each	  polymer	  molecular	  weight,	  inhibition	  of	  NO	  production	  
was	   statistically	   significant	   when	   compared	   to	   LPS-­‐stimulated	   macrophages	   and	   also	   significant	   when	  
compared	  to	  the	  same	  polymer	  administered	  in	  solution	  phase.	  Commercially	  available	  inhibitor	  of	  iNOS	  (L-­‐
NAME)	  afforded	  an	  >50%	  reduction	  in	  the	  levels	  of	  produced	  NO.	  	  
Pro-­‐	  and	  anti-­‐	  inflammatory	  signals	  can	  exert	  their	  effect	  both,	  from	  the	  outside	  and	  inside	  of	  the	  cell,	  i.e.	  
act	  on	  the	  surface-­‐localized	  receptors	  or	   intracellular	  receptors	  /	  enzymes.5	  PVA	  polymer	  chains	  are	  well-­‐
known	   to	   be	   low	   fouling	   and	   undergo	   minimal	   if	   any	   internalization	   by	   mammalian	   cells.	   In	   turn,	  
macrophages	   are	   professional	   phagocytic	   cells	   which	   internalize	   nanoparticles,	   microparticles,	  
microcapsules,	   and	   even	   cells.	   Polymers	   as	   solutions	   and	   HNP	   were	   administered	   at	   matched	   doses	   (in	  
terms	   of	   administered	   polymer	  mass).	   Further,	   taking	   into	   account	   the	   labile,	   (bio)degradable	   nature	   of	  
PVA	  physical	  hydrogels,28	   it	   is	   likely	   that	  PVA	  HNP	  released	  polymer	  chains	   from	  the	  hydrogel	  phase	   into	  
suspensions	   over	   cultured	   cells.	   From	   this,	   it	   is	   possibly	   to	   conclude	   inhibition	   of	   production	   of	   NO	   as	  
observed	  in	  our	  experiments	  was	  not	  mediated	  by	  PVA	  polymer	  chains	  in	  solutions.	  However,	  this	  mode	  of	  
activity	  cannot	  be	  fully	  ruled	  out	  for	  HNP	  in	  which	  case	  clustering	  of	  chains	  into	  nanoparticles	  may	  possibly	  
give	  rise	  to	  increased	  association	  of	  particles	  with	  cells	  and	  receptors	  on	  their	  membranes.	  From	  a	  different	  
perspective,	   upon	   cell	   entry,	   activity	   may	   possibly	   be	   exerted	   by	   HNP	   and	   possibly	   individual	   polymer	  
chains	  released	  therefrom	  as	  well.	  The	  pathway	  of	  receptor	  mediated	  activation	  of	  macrophages	  using	  LPS,	  
subsequent	   cascade	  of	   events	   leading	   to	   activation	   of	  NF-­‐κB,	   increased	   cellular	   production	   of	   iNOS,	   and	  
finally	   the	   synthesis	   of	   NO	   is	   very	   complex;	   understanding	   the	   origin	   of	   revealed	   activity	   of	   PVA	   HNP	  
therefore	  requires	  extensive	  biochemical	  experiments	  well	  exceeding	  the	  scope	  of	  this	  work,	  and	  this	  is	  the	  
subject	  of	  ongoing	  research.	  
	  
CONCLUSIONS	  
In	   this	   work,	   we	   developed	   production	   of	   PVA	   HNP	   through	   a	   combination	   of	   nanoprecipitation	   as	   a	  
method	   to	   produce	   polymer	   nanoparticles	   and	   subsequent	   non-­‐cryogenic	   hydrogelation.	   PVA	  HNP	  were	  
assembled	  using	  polymer	  samples	  with	  molecular	  weights	  varying	  over	  a	  wide	  range,	  from	  as	  low	  as	  13	  kDa	  
to	   190	   kDa.	   Assembled	   hydrogel	   nanoparticles	   revealed	   near	   zero	   zeta	   potential	   but	   exhibited	   excellent	  
colloidal	  stability.	  In	  cultured	  macrophages,	  PVA	  HNP	  exerted	  no	  pro-­‐inflammatory	  activity	  but	  revealed	  a	  
pronounced	  anti-­‐inflammatory	  action	  manifested	  as	   inhibition	  of	  production	  of	  nitric	  oxide	  by	  stimulated	  
macrophages.	  We	   strongly	  believe	   that	   this	   is	   the	   first	   example	  of	   anti-­‐inflammatory	  activity	  of	  hydrogel	  
nanoparticles	  which	  renders	  PVA	  HNP	  promising	  candidates	  for	  diverse	  biomedical	  applications,	  specifically	  
drug	  delivery	  and	  assembly	  of	  intracellular	  biosensors.	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